Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: At $0.042, the current capitalization of PTSC is less then $17 million.

What this indicates to me and there is probably more to it but even so companies

with serious exposure to the mmp are not very concerned about ptsc coming after them.

You figure companies can piss on $17 million..yet they would rather ptsc take

them to court and risk a jury ruling than buy our patent.

Share
New Message
Please login to post a reply